Mesa Verde Venture Partners: Funding, Team & Investors | Startup Intros

Loading organizations...

Mesa Verde Venture Partners: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 25, 2020	CalciMedica	$15.0M Series C	Eric Roberts	Bering Capital, Sanderling Ventures
Jun 19, 2019	NeuraLace Medical	$3.9M Seed	—	FusionX Ventures, Fred Middleton, MooDoos Investments, Teal Ventures
May 1, 2019	Paradigm Diagnostics	$15.0M Series B	—	BlueStone Venture Partners, John Friedman, Stan Lynall, Prairie Ventures, Tech Coast Angels
Jan 3, 2019	Immusoft	$20.0M Series B	—	Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, RBV Capital
Jan 27, 2017	Biscayne NeuroTherapeutics	$3.0M Series B	Karimah Es Sabar	Carey J. Ng
Nov 16, 2016	Paradigm Diagnostics	$7.0M Series B	Carey J. Ng	—
Feb 18, 2015	Lineagen	$16.2M Debt / Series C	David Kabakoff	Archipel Capital, Kickstart Ventures, Mountain Group Partners, David Fitzgerald, PrairieGold Venture Partners, Sanderling Ventures, Signal Peak Ventures, Silicon Valley Bank, University Venture Fund
Dec 18, 2013	Lineagen	$3.5M Other Equity / Series C	Sanderling Ventures, Signal Peak Ventures	Archipel Capital, Hatteras Funds, Kickstart Seed Fund, PrairieGold Venture Partners, University Venture Fund
Jan 1, 2012	Elevation Pharmaceuticals	$30.0M Series B	Heath Lukatch	Canaan Partners, Red Tree Venture Capital, Canaan Partners, Care Capital, TPG Biotech
Sep 1, 2011	Elevation Pharmaceuticals	$17.0M Series A	—	Canaan Partners, Canaan Partners, Care Capital, TPG Biotech
Jan 4, 2011	Lineagen	$15.0M Series B	—	PrairieGold Venture Partners, Sanderling Ventures, Signal Peak Ventures
Jan 1, 2010	Elevation Pharmaceuticals	$30.0M Series A	—	Canaan Partners, Brent Ahrens, Jan Leschly, Heather Preston
Dec 6, 2007	Lineagen	$6.0M Other Equity	—	Sanderling Ventures, Signal Peak Ventures